Apimeds Pharmaceuticals US (APUS) P/E (2025 - 2026)
Apimeds Pharmaceuticals US (APUS) P/E from May 9, 2025 to Jul 20, 2026. The TTM Apimeds Pharmaceuticals US (APUS) P/E is -0.20. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Apimeds Pharmaceuticals US (APUS)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.20 | -94.06% |
| 2025 | -3.31 | N/A |
Comparison Apimeds Pharmaceuticals US (APUS) P/E with competitors
Apimeds Pharmaceuticals US (APUS) P/E is -0.20.